Dr Reddy’s Laboratories reeled early Monday, plunging 9% after the New Jersey District Court granted a preliminary injunction against the sale of the generic version of Suboxone used for treating opioid dependence.
The stock crashed 9.48% to hit a low of Rs 2,097.70 on the BSE.
For more information on commodity tips
and quick free trial click here > 911 133 9000
Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
Sign up here with your email